MedPath

Comparative Study of Zataria Multiflora Boiss Vaginal Cream and Clotrimazol in Candida Vaginitis treatment

Not Applicable
Conditions
Candida Vaginitis.
Candidiasis of Vulva and Vagina
Registration Number
IRCT138807112537N1
Lead Sponsor
Vice-chancellor for Research, Jondishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
73
Inclusion Criteria

signs and symptoms of Candida vaginitis, positive direct smear of vaginal discharge
Exclusion criteria: pregnant women, low compliance, any drug hypersensitivity, recurrent Candida vaginitis (4 or more Candida vaginitis in a year), consumption of immunosuppressive drug or widespread antibiotics, history of epilepsy, diabetes, heart disease, high blood pressure, thyroid diseases, or advanced arthritis, using other vaginal creams or suppositories during the study period, consumption of systemic antifungal drugs during 4 weeks prior to the study, presence of non-candidal vaginitis, consumption of oral contraceptives.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Discharge. Timepoint: Baseline and3 to 4 Days after treatment. Method of measurement: Clinical Examination, observation, and medical history.;Pruritus. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: History.;Edema. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: Clinical Examination, observation, and medical history.;Erythema symptoma. Timepoint: Baseline and 3 to 4 Days after treatment. Method of measurement: Clinical Examination, Observation, and History.;Dysuria Symptom. Timepoint: Baseline and 3-4 Days after treatment. Method of measurement: History.;Dysparonia Symptom. Timepoint: Baseline and 3 to 4 Days after the treatment. Method of measurement: History.;Culture results. Timepoint: 3 to 4 Days after Treatment. Method of measurement: Wet Smear and Vaginal Culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath